| Recruitment status | Main results already published |
| Unique ID issued by UMIN | UMIN000032136 |
| Receipt No. | R000036597 |
| Scientific Title | A Study on the Effect of Food Containing Plant Extract on LDL-cholesterol Levels -A Randomized, Double-blind, Placebo-controlled, Parallel-group Study- |
| Date of disclosure of the study information | 2018/04/06 |
| Last modified on | 2020/04/17 (Ver. 4) |
| Basic information | ||
| Public title | A Study on the Effect of Food Containing Plant Extract on LDL-cholesterol Levels -A Randomized, Double-blind, Placebo-controlled, Parallel-group Study- | |
| Acronym | A Study on the Effect of Food Containing Plant Extract on LDL-cholesterol Levels | |
| Scientific Title | A Study on the Effect of Food Containing Plant Extract on LDL-cholesterol Levels -A Randomized, Double-blind, Placebo-controlled, Parallel-group Study- | |
| Scientific Title:Acronym | A Study on the Effect of Food Containing Plant Extract on LDL-cholesterol Levels | |
| Region |
|
|
| Condition | ||
| Condition | No | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To assess the efficacy of food containing plant extract on LDL-cholesterol levels |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | LDL-cholesterol |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Double blind -all involved are blinded |
| Control | Placebo |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Foods containing plant extract, 12 weeks consumption | |
| Interventions/Control_2 | Foods not containing plant extract, 12 weeks consumption | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | (1) Healthy males and females aged 20 to 64 years-old.
(2) Subjects whose BMI are 18.5 or over and under 30. (3) Subjects whose LDL-cholesterol levels are under 140 mg/dL. (4) Subjects who can make self-judgment and are voluntarily giving written informed consent. |
|||
| Key exclusion criteria | (1) Subjects who habitually use medications.
(2) Subjects who can't stop using supplements and/or functional foods (including Food for Specified Health Uses and/or Foods with Function Claims) affecting obesity, hyperlipidemia, lipid metabolism, and so on during test periods. (3) Subjects who can't stop drinking from 2 days before each measurement. (4) Subjects who contract or are under treatment for serious diseases (e.g., liver disease, kidney disease, digestive disease, heart disease, respiratory disease, endocrine disease, and/or metabolic disease). (5) Subjects who have declared allergic reaction to ingredients of test foods. (6) Subjects who are under treatment for or have a history of drug addiction and/or alcoholism. (7) Subjects who are shiftworker and/or midnight-shift worker. (8) Subjects who have been diagnosed as familial hyperlipidemia. (9) Subjects who are planning to become pregnant after informed consent for the current study, pregnant or lactating. (10) Subjects who are planning to participate and/or had participated in other clinical studies within the last one month prior to the current study. (11) Subjects who are judged as unsuitable for the current study by the investigator for other reasons. |
|||
| Target sample size | 100 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Shinagawa Season Terrace Health Care Clinic | ||||||
| Division name | Medical examination and treatment management family chief director | ||||||
| Zip code | 108-0075 | ||||||
| Address | 1-2-70 Konan, Minato-ku, Tokyo | ||||||
| TEL | 03-3452-3381 | ||||||
| satoru_suzuki@sempos.or.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | KSO Corporation | ||||||
| Division name | Sales department | ||||||
| Zip code | 105-0023 | ||||||
| Address | 1-9-7 Shibaura, Minato-ku, Tokyo | ||||||
| TEL | 03-3452-7733 | ||||||
| Homepage URL | |||||||
| yoshi@kso.co.jp | |||||||
| Sponsor | |
| Institute | KSO Corporation |
| Institute | |
| Department | |
| Funding Source | |
| Organization | TOYO SHINYAKU Co., Ltd. |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Ethical Committee of Shinagawa Season Terrace Health Care Clinic |
| Address | 1-2-70, Konan, Minato-ku, Tokyo The 5th floor of Shinagawa season terrace |
| Tel | 03-3452-3382 |
| tomohiro_kogo@sempos.or.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | https://upload.umin.ac.jp/cgi-open-bin/ctr/ctr_view.cgi?recptno=R000036597 |
| Publication of results | Published |
| Result | |||||||
| URL related to results and publications | http://www.pieronline.jp/content/article/0386-3603/47040/629 | ||||||
| Number of participants that the trial has enrolled | 100 | ||||||
| Results | Statistically significant difference was confirmed in the primary outcome. |
||||||
| Results date posted |
|
||||||
| Results Delayed | |||||||
| Results Delay Reason | |||||||
| Date of the first journal publication of results | |||||||
| Baseline Characteristics | Males and females aged 20 to 64 years old. |
||||||
| Participant flow | Enrolled(n=100) Completed(n=99) Analysed(n=86) |
||||||
| Adverse events | No adverse events were observed that be related to test food. |
||||||
| Outcome measures | LDL-cholesterol |
||||||
| Plan to share IPD | |||||||
| IPD sharing Plan description | |||||||
| Progress | |||||||
| Recruitment status | Main results already published | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000036597 |